People · Operator
Named in public records as an officer, director or promoter · active 2008–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Glycomimetics Inc | — | Pharmaceuticals | Series B | $54.3M | $1.3B | 2008 |
Rachel King at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rachel King on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| M. James Barrett | 1 | 6 |
| Michael James Henos | 1 | 1 |
| Franklin James Top | 1 | 1 |
| Helen Thackray | 1 | 1 |
| John Magnani | 1 | 1 |
| John James Baldwin | 1 | 1 |
| William James Gust | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.